Prognostic Significance of Concurrent MYC, BCL2 and/or BCL6 Expression in Diffuse Large B-Cell Lymphoma

Relationship between C-MYC, BCL-2 and BCL-6 Genetic Abnormalities and Bone Marrow Biopsy in B-Non-Hodgkin Lymphoma

Prognostic value of CD10, BCL6 and MUM1 in diffuse large B-cell lymphoma

Prognostic Significance of Beclin 1 Expression in Diffuse Large B Cell Lymphoma Patients Receiving Immuno-chemotherapy at Zagazig University and Health Insurance Hospitals

Evaluation of t(14;18)(q32;q21) and BCL2 protein and their prognostic role in follicular lymphoma

Clinicopathological Significance of A20 Genetic Mutation in Diffuse Large B-Cell Lymphoma

DIAGNOSTIC AND PROGNOSTIC SIGNIFICANCE OF BONE MARROW BIOPSY IN NON HODGKINS LYMPHOMA

Prognostic Relevance of CD69, Vascular Endothelial Growth Factor and Thymidine Kinase in B-Chronic Lymphocytic Leukemia

PROGNOSTIC VALUE OF CTBP2 AND CASP8AP2 EXPRESSION IN ADULT ACUTE B-CELL LYMPHOBLASTIC LEUKEMIA PATIENTS

PROGNOSTIC SIGNIFICANCE OF BCL-2, BAX AND P53 EXPRESSION IN BREAST CANCER